基于计算机体层摄影的无创影像在肝细胞癌患者首次经动脉化疗栓塞术后疗效评估中的效能与可解释性分析
本研究为回顾性研究,纳入中心1的279例肝细胞癌患者按4:1分为训练集与验证集,中心2的72例作为外部测试集;基于动脉期和静脉期增强CT影像组学特征构建联合模型,三个队列的AUC分别为0.865、0.800和0.745,并通过转录组数据探索了影像组学特征的生物学可解释性。
要点
- 基于增强CT动脉期和静脉期影像组学特征构建的联合模型可用于预测肝细胞癌患者首次TACE术后疗效,外部测试集AUC为0.745。
- 动脉期筛选出31个影像组学特征构建Radscore_arterial,静脉期筛选出13个特征构建Radscore_venous,二者均为独立危险因素。
- 动脉期11个影像组学特征与8个基因模块相关,静脉期4个特征与5个基因模块相关(均P<.05),富集于与肿瘤发生和增殖密切相关的通路。
核心结论
- 基于增强CT的无创影像在预测肝细胞癌患者首次TACE术后疗效方面具有相当的价值,影像组学特征可在微观层面映射其生物学可解释性。
研究设计与样本
- 回顾性研究,中心1纳入279例肝细胞癌患者按4:1分为训练集与验证集,中心2纳入72例作为外部测试集;基于增强CT动脉期和静脉期影像组学特征构建预测模型,采用单因素分析、相关性分析和LASSO回归筛选特征,经单因素和多因素logistic回归分析确定独立危险因素构建临床模型和联合模型,并利用公开数据集关联转录组测序数据探索生物学可解释性。
诊断标准与关键数值
- 联合模型在训练集、验证集和外部测试集的AUC分别为0.865、0.800和0.745;动脉期筛选出31个影像组学特征构建Radscore_arterial,静脉期筛选出13个影像组学特征构建Radscore_venous,二者均为独立危险因素;动脉期11个影像组学特征与8个基因模块相关,静脉期4个影像组学特征与5个基因模块相关(均P<.05)。
临床应用与阅片要点
- 作者认为基于增强CT的无创影像在预测肝细胞癌患者首次TACE术后疗效方面具有相当的价值,影像组学特征的生物学可解释性可在微观层面进行映射。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The objective of this study is to accurately and timely assess the efficacy of patients with hepatocellular carcinoma (HCC) after the initial transarterial chemoembolization (TACE).
MATERIALS AND METHODS: This retrospective study consisted of 279 patients with HCC in Center 1, who were split into training and validation cohorts in the ratio of 4:1, and 72 patients in Center 2 as an external testing cohort. Radiomics signatures both in the arterial phase and venous phase of contrast-enhanced computed tomography images were selected by univariate analysis, correlation analysis, and least absolute shrinkage and selection operator regression to build the predicting models. The clinical model and combined model were constructed by independent risk factors after univariate and multivariate logistic regression analysis. The biological interpretability of radiomics signatures correlating transcriptome sequencing data was explored using publicly available data sets.
RESULTS: A total of 31 radiomics signatures in the arterial phase and 13 radiomics signatures in the venous phase were selected to construct Radscore_arterial and Radscore_venous, respectively, which were independent risk factors. After constructing the combined model, the area under the receiver operating characteristic curve in three cohorts was 0.865, 0.800, and 0.745, respectively. Through correlation analysis, 11 radiomics signatures in the arterial phase and 4 radiomics signatures in the venous phase were associated with 8 and 5 gene modules, respectively (All P < .05), which enriched some pathways closely related to tumor development and proliferation.
CONCLUSION: Noninvasive imaging has considerable value in predicting the efficacy of patients with HCC after initial TACE. The biological interpretability of the radiological signatures can be mapped at the micro level.
引用
- Dai, Liu, Xin, et al. Efficacy and Interpretability Analysis of Noninvasive Imaging Based on Computed Tomography in Patients with Hepatocellular Carcinoma After Initial Transarterial Chemoembolization. Acad Radiol. 2023. PMID: 37393179. doi:10.1016/j.acra.2023.05.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。